Publications by authors named "Dimitris Repantis"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

7,361

Total Likes

876

Extended Reach

1,762,148

Social Features

234
C
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, Robin Carhart-Harris, Jamie Chai-Rees, Dimitris Repantis

J Affect Disord· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The List to Nowhere: Last-Come, First-Served in High-Demand Psychiatric Services.
Christopher Poppe, Dimitris Repantis

Am J Bioeth· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.
Chiara Caporuscio, Christopher Poppe, Astrid Gieselmann, Dimitris Repantis

Psychol Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Offering Psychedelic Treatments Before Assisted Dying for Psychiatric Conditions.
Christopher Poppe, Jan Christoph Bublitz, Dimitris Repantis

JAMA Psychiatry· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, Robin Carhart-Harris, Jamie Chai-Rees, Dimitris Repantis

J Affect Disord· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethical Aspects of Psychedelic-Assisted Treatments: An Overview.
Christopher Poppe, Dimitris Repantis

Curr Top Behav Neurosci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control side effects of the psychedelic renaissance.
Christoph Bublitz, Nicolas Langlitz, Dimitris Repantis

Nature· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, Merve Atli, James C Bennett, Dimitris Repantis

J Affect Disord· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive enhancement: Effects of methylphenidate, modafinil, and caffeine on latent memory and resting state functional connectivity in healthy adults.
Maxi Becker, Dimitris Repantis, Martin Dresler, Simone Kühn

Hum Brain Mapp· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol for "MDMA-assisted therapy as a treatment for major depressive disorder: A proof of principle study".
Tor-Morten Kvam, Ivar W Goksøyr, Lowan H Stewart, Dimitris Repantis, Jan Ivar Røssberg

Front Psychiatry· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memory enhancement with stimulants: Differential neural effects of methylphenidate, modafinil, and caffeine. A pilot study.
Lucas C Adam, Dimitris Repantis, Boris N Konrad, Martin Dresler, Simone Kühn

Brain Cogn· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics.
Nicolas Langlitz, Erika Dyck, Milan Scheidegger, Dimitris Repantis

Front Psychiatry· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Central Clearing Clinic to Provide Mental Health Services for Refugees in Germany.
Malek Bajbouj, Patricia Panneck, Sibylle-Maria Winter, Carlos Ajami, Jihad Alabdullah, Dimitris Repantis

Front Public Health· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine.
Dimitris Repantis, Leonore Bovy, Kathrin Ohla, Simone Kühn, Martin Dresler

Psychopharmacology (Berl)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memory, Authenticity, and Optogenethics.
Jan Christoph Bublitz, Dimitris Repantis

AJOB Neurosci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REM sleep in acutely traumatized individuals and interventions for the secondary prevention of post-traumatic stress disorder.
Dimitris Repantis, Katharina Wermuth, Nikolaos Tsamitros, Heidi Danker-Hopfe, Jan Christoph Bublitz

Eur J Psychotraumatol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hacking the Brain: Dimensions of Cognitive Enhancement.
Martin Dresler, Anders Sandberg, Christoph Bublitz, Kathrin Ohla, Carlos Trenado, Dimitris Repantis

ACS Chem Neurosci· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxazosin, an α-1-adrenergic-receptor Antagonist, for Nightmares in Patients with Posttraumatic Stress Disorder and/or Borderline Personality Disorder: a Chart Review.
Stefan Roepke, Heidi Danker-Hopfe, Dimitris Repantis, Behnoush Behnia, Florian Bernard

Pharmacopsychiatry· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Securing Opportunities for the Disadvantaged, or Medicalization Through the Back Door?
Fred B Ketchum, Dimitris Repantis

Am J Bioeth· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feeling smart: Effects of caffeine and glucose on cognition, mood and self-judgment.
Susann Ullrich, Yfke C de Vries, Simone Kühn, Dimitris Repantis, Martin Dresler

Physiol Behav· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review.
Guillaume Fond, Jean-Arthur Micoulaud-Franchi, Lore Brunel, Alexandra Macgregor, Stéphanie Miot, Dimitris Repantis

Psychiatry Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating the enhancement landscape. Ethical issues in research on cognitive enhancers for healthy individuals.
Cynthia Forlini, Wayne Hall, Bruce Maxwell, Simon M Outram, Peter B Reiner, Dimitris Repantis

EMBO Rep· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-pharmacological cognitive enhancement.
Martin Dresler, Anders Sandberg, Kathrin Ohla, Christoph Bublitz, Carlos Trenado, Dimitris Repantis

Neuropharmacology· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.
Dimitris Repantis, Peter Schlattmann, Oona Laisney, Isabella Heuser

Pharmacol Res· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis